This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


OncoTherapy Science, Inc.

Drug Names(s): OTS167IV, OTS167PO

Description: OTS167 is a targeted compound that has a potent inhibitory activity on MELK (maternalembryonic leucine zeipper kinase), a novel protein kinase in formation and maintenance of cancerstem cells. Experiments using xenograft mice models have demonstrated that OTS167 shows potentanti-tumor activities against lung, prostate, breast and pancreatic cancers.

OTS167 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug